[Vitamin D status in 6- to 10-year-old children: a French multicenter study in 326 children]

E Mallet1, J Gaudelus2, P Reinert3

  • 1Centre de référence des maladies rares du calcium et du phosphore, CIC Inserm 204 antenne pédiatrique, CHU de Rouen, 1, rue de Germont, 76000 Rouen, France.

Insights

Vitamin D deficiency affects over one-third of French children aged 6-10 years. Supplementation significantly reduces deficiency risk, with no severe cases observed in supplemented children.

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Science
  • Public Health

Context:

  • Vitamin D status is crucial for children's health, yet data for French children aged 6-10 years is limited.
  • Seasonal variations in sunshine significantly impact vitamin D levels, particularly in northern regions.

Purpose:

  • To evaluate the vitamin D status in French children aged 6-10 years.
  • To determine the prevalence of vitamin D deficiency and identify associated factors.

Summary:

  • A study involving 326 children found that 3.1% had severe vitamin D deficiency and 34.4% had vitamin D deficiency (25(OH)D levels ≤50 nmol/L).
  • Children in northern France exhibited lower vitamin D levels compared to those in the south.
  • Vitamin D supplementation was associated with a significantly lower risk of deficiency, with no severe cases reported in supplemented children.

Impact:

  • Findings highlight a substantial public health concern regarding vitamin D deficiency in French children.
  • Results strongly support the recommendation for vitamin D supplementation during winter for children aged 6-10 years.
  • This study provides essential data to inform future guidelines on vitamin D intake for pediatric populations.
Abstract

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
547
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
241